| NCT05941715 | Medical University of Graz | Neovascular Age-related Macular Degeneration | 2023-07-04 | PHASE4 |
| NCT06124677 | Rigshospitalet, Denmark | Neovascular Age-related Macular Degeneration | 2023-11-01 | |
| NCT06890026 | Rigshospitalet, Denmark | Neovascular Age-Related Macular Degeneration (nAMD)|Treatment-na?ve | 2024-11-15 | |
| NCT07526857 | Federico II University | Diabetic Retinopathy, DR | 2025-01-01 | |
| NCT06680817 | Hoffmann-La Roche | Neovascular Age-related Macular Degeneration|Diabetic Macular Edema | 2025-02-05 | |
| NCT03823287 | Hoffmann-La Roche | Wet Macular Degeneration | 2019-02-19 | PHASE3 |
| NCT06191094 | University of Colorado, Denver | Diabetic Retinopathy|Vitreous Hemorrhage Due to Diabetes Mellitus | 2024-07-12 | PHASE4 |
| NCT05844982 | Jaeb Center for Health Research|National Eye Institute (NEI)|National Institutes of Health (NIH)|Alimera Sciences|Genentech, Inc. | Radiation Retinopathy|Visual Impairment | 2023-11-21 | PHASE3 |
| NCT07425522 | Genentech, Inc. | Diabetic Macular Edema | 2026-04-21 | PHASE1 |
| NCT06231121 | Rigshospitalet, Denmark | Neovascular Age-related Macular Degeneration | 2023-12-01 | |
| NCT06439576 | Hoffmann-La Roche|Shanghai Roche Pharmaceutical Co., Ltd | Diabetic Macular Edema|Neovascular Age-related Macular Degeneration|Retinal Vein Occlusion | 2024-05-09 | |
| NCT04597918 | Hoffmann-La Roche | Diabetic Macular Edema | 2020-11-25 | PHASE2 |
| NCT06908876 | Innovent Biologics Technology Limited (Shanghai R&D Center) | Diabetic Macular Oedema | 2025-04-24 | PHASE2 |
| NCT05610319 | McMaster University|Hoffmann-La Roche | Diabetic Macular Edema | 2023-05-01 | PHASE4 |
| NCT07249216 | Singapore National Eye Centre | Age Related Macular Degeneration | 2025-07-18 | NA |
| NCT05569148 | Hoffmann-La Roche | Neovascular Age-related Macular Degeneration|Diabetic Macular Edema | 2022-10-17 | PHASE3 |
| NCT07484074 | Ollin Biosciences, Inc. | Diabetic Macular Edema (DME)|Neovascular (Wet) Age-Related Macular Degeneration | 2025-02-12 | PHASE1 |
| NCT04740905 | Hoffmann-La Roche|Chugai Pharmaceutical | Macular Edema|Branch Retinal Vein Occlusion | 2021-03-02 | PHASE3 |
| NCT04432831 | Hoffmann-La Roche | Diabetic Macular Edema | 2020-08-05 | PHASE3 |
| NCT02484690 | Hoffmann-La Roche | Choroidal Neovascularization | 2015-08-11 | PHASE2 |
| NCT03622580 | Hoffmann-La Roche | Diabetic Macular Edema | 2018-09-05 | PHASE3 |
| NCT03038880 | Hoffmann-La Roche | Neovascularization, Choroidal|Macular Degeneration, Age-Related | 2017-01-27 | PHASE2 |
| NCT07367282 | Junyeop Lee | Macular Degeneration | 2026-04-01 | PHASE4 |
| NCT03823300 | Hoffmann-La Roche | Wet Macular Degeneration | 2019-03-11 | PHASE3 |
| NCT05904028 | Jaeb Center for Health Research|National Institutes of Health (NIH)|National Eye Institute (NEI)|Juvenile Diabetes Research Foundation | Neovascular Age-related Macular Degeneration | 2023-11-09 | PHASE3 |
| NCT07187804 | Kim´s Eye Hospital | Age-related Macular Degeneration (ARMD)|Choroidal Neovascularization|Anti-vascular Endothelial Growth Factor | 2025-09-23 | PHASE4 |
| NCT06271330 | Nantes University Hospital|Rennes University Hospital | Age-related Macular Degeneration | 2024-04-01 | |
| NCT06742307 | Hospital Authority, Hong Kong | Macular Degeneration Choroidal Neovascularization | 2025-08-21 | PHASE4 |
| NCT07144865 | Bojie Hu | Proliferative Diabetic Retinopathy | 2024-12-01 | NA |
| NCT05224102 | Genentech, Inc. | Diabetic Macular Edema | 2022-02-28 | PHASE4 |
| NCT07093385 | University of Baghdad | Age-Related Macular Degeneration | 2024-09-10 | PHASE2 |
| NCT06795048 | Hoffmann-La Roche | Neovascular Age-related Macular Degeneration (nAMD) | 2025-03-14 | PHASE4 |
| NCT06572553 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Age-Related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion | 2024-03-01 | PHASE2|PHASE3 |
| NCT05476926 | Hoffmann-La Roche | Neovascular Age-related Macular Degeneration|Diabetic Macular Edema|Retinal Vein Occlusion|Branch Retinal Vein Occlusion|Central Retinal Vein Occlusion|Hemi-retinal Vein Occlusion | 2022-11-21 | |
| NCT04777201 | Hoffmann-La Roche | Neovascular Age-related Macular Degeneration | 2021-04-19 | PHASE3 |
| NCT06902207 | Rigshospitalet, Denmark | Intraocular Inflammation | 2024-11-10 | |
| NCT06790784 | Jaeb Center for Health Research|National Eye Institute (NEI)|Genentech, Inc. | Proliferative Diabetic Retinopathy (PDR) | 2025-08-04 | PHASE3 |
| NCT02699450 | Hoffmann-La Roche | Diabetic Macular Edema | 2016-04-27 | PHASE2 |
| NCT04740931 | Hoffmann-La Roche|Chugai Pharmaceutical | Macular Edema|Central Retinal Vein Occlusion|Hemiretinal Vein Occlusion | 2021-03-02 | PHASE3 |
| NCT07461441 | Yeungnam University College of Medicine | Polypoidal Choroidal Vasculopathy (PCV)|Age Related Macular Degeneration | 2026-03-01 | PHASE3 |
| NCT06929507 | University Hospital, Alexandroupolis | Renal Function Disorder|Diabetic Macular Edema (DME)|Neovascular Age Related Macular Degeneration | 2025-03-10 | NA |
| NCT06176352 | Hoffmann-La Roche | Choroidal Neovascularization Secondary to Pathologic Myopia | 2024-03-06 | PHASE3 |
| NCT06709339 | Association for Innovation and Biomedical Research on Light and Image | Polypoidal Choroidal Vasculopathy | 2025-08-06 | PHASE4 |
| NCT06850922 | Genentech, Inc. | Diabetic Macular Edema | 2022-06-22 | PHASE1|PHASE2 |
| NCT07088445 | Hui Peng | Neovascular Age-related Macular Degeneration(nAMD) | 2025-09-01 | |
| NCT07520045 | Osijek University Hospital | Diabetic Retinopathy (DR)|Diabetic Macular Edema (DME) | 2026-03-12 | NA |
| NCT06875245 | Faculty Hospital Kralovske Vinohrady | Wet Age-related Macular Degeneration | 2023-03-31 | PHASE4 |
| NCT01941082 | Hoffmann-La Roche | Macular Degeneration | 2013-12 | PHASE1 |